{"id":86947,"date":"2022-12-01T18:10:00","date_gmt":"2022-12-01T11:10:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2022120118100086947"},"modified":"2022-12-01T23:04:11","modified_gmt":"2022-12-01T15:04:11","slug":"%e7%bb%b4%e4%ba%9a%e7%94%9f%e7%89%a912%e5%ae%b6%e6%8a%95%e8%b5%84%e5%ad%b5%e5%8c%96%e4%bc%81%e4%b8%9a%e8%bf%91%e6%9c%9f%e5%8f%91%e5%b1%95%e5%8a%a8%e6%80%81%e4%b8%80%e8%a7%88","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2022120118100086947","title":{"rendered":"\u7ef4\u4e9a\u751f\u726912\u5bb6\u6295\u8d44\u5b75\u5316\u4f01\u4e1a\u8fd1\u671f\u53d1\u5c55\u52a8\u6001\u4e00\u89c8"},"content":{"rendered":"<p><p><span class=\"legendSpanClass\">\u4e0a\u6d77<\/span><span class=\"legendSpanClass\">2022\u5e7412\u67081\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212;&nbsp;\u9762\u5bf9\u4e0d\u65ad\u53d8\u5316\u7684\u5c40\u52bf\uff0c\u6280\u672f\u521b\u65b0\u4f9d\u65e7\u662f\u751f\u7269\u533b\u836f\u4f01\u4e1a\u957f\u8fdc\u53d1\u5c55\u6c38\u6052\u7684\u4e3b\u65cb\u5f8b\uff0c\u4e3a\u4f01\u4e1a\u6e90\u6e90\u4e0d\u65ad\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7eed\u63a8\u52a8\u7814\u53d1&quot;\u4ece0\u52301&quot;\u8f6c\u5316\u4ee5\u53ca\u5546\u4e1a\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7ef4\u4e9a12\u5bb6\u6295\u8d44\u5b75\u5316\u4f01\u4e1a\u53d6\u5f97\u4e86\u663e\u8457\u7684\u6210\u679c\u4e0e\u8fdb\u5c55\uff1aFocus-X Therapeutics\u4e0e\u8f90\u8054\u533b\u836f\u6210\u529f\u8fbe\u6210\u6536\u8d2d\u534f\u8bae\uff1bAleta Biotherapeutics\u3001Domain\u3001Triumvira\u3001\u74a7\u8fb0\u533b\u836f\u3001\u542f\u6108\u751f\u7269\u987a\u5229\u63a8\u8fdb\u7814\u53d1\u7ba1\u7ebf\uff1b\u5b50\u77bb\u751f\u7269\u3001Cybrexa\u3001\u5b89\u6d4e\u836f\u4e1a\u5206\u522b\u5728\u5404\u81ea\u7ec6\u5206\u9886\u57df\u8fbe\u6210\u91cd\u8981\u5408\u4f5c\uff1bDTx Pharma\u3001HAYA Therapeutics\u3001\u7d22\u667a\u751f\u7269\u63a5\u8fde\u65a9\u83b7\u6b8a\u8363\u3002\u4e0b\u9762\uff0c\u8ba9\u6211\u4eec\u5171\u540c\u4e00\u89c8\u4ed6\u4eec\u7684\u53d1\u5c55\u52a8\u6001\u3002<\/p>\n<p><b>\u7ef4\u4e9a\u751f\u7269\u6295\u8d44\u5b75\u5316\u516c\u53f8<\/b><b>Focus-X Therapeutics\uff0c\u4e0e\u8f90\u8054\u533b\u836f\u6210\u529f\u8fbe\u6210\u6536\u8d2d\u534f\u8bae<\/b><\/p>\n<p>2022\u5e7411\u670829\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u6295\u8d44\u5b75\u5316\u7684\u6838\u7d20\u836f\u7269\u516c\u53f8Focus-X Therapeutics\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;Focus-X&quot;\uff09\uff0c\u4e0e\u8f90\u8054\u533b\u836f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;\u8f90\u8054\u533b\u836f&quot;\uff09\u6210\u529f\u8fbe\u6210\u6536\u8d2d\u534f\u8bae\u3002\u6839\u636e\u6b64\u6b21\u6536\u8d2d\u534f\u8bae\u6761\u6b3e\uff0c\u8f90\u8054\u533b\u836f\u5c06\u652f\u4ed8Focus-X\u603b\u8ba12.45\u4ebf\u7f8e\u5143\u7684\u4ea4\u6613\u5bf9\u4ef7\uff0c\u5176\u4e2d\u5305\u62ec\u9884\u4ed8\u6b3e\u4ee5\u53ca\u6f5c\u5728\u7684\u5f00\u53d1\u3001\u6ce8\u518c\u3001\u9500\u552e\u91cc\u7a0b\u7891\u8d39\u7528\u548c\u5546\u4e1a\u9500\u552e\u7684\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\u3002\u8be5\u9879\u6536\u8d2d\u9884\u8ba1\u5c06\u4e8e2023\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u3002\u8fd9\u4e5f\u662f\u7ef4\u4e9a\u6295\u8d44\u5b75\u5316\u516c\u53f8\u4e2d\u7ee7Dogma\u3001Totient\u540e\u53c8\u4e00\u4e2a\u5728\u4e34\u5e8a\u524d\u9636\u6bb5\u88ab\u6536\u8d2d\u7684\u9879\u76ee\uff0c\u518d\u6b21\u9a8c\u8bc1\u4e86\u7ef4\u4e9a\u6295\u8d44\u56e2\u961f\u53d1\u6398\u9879\u76ee\u7684\u80fd\u529b\u4ee5\u53ca\u4e13\u4e1a\u7684\u6295\u540e\u652f\u6301\u3002<\/p>\n<p>Focus-X\u662f\u4e00\u5bb6\u57fa\u4e8e\u81ea\u8eab\u4e13\u6709\u7684\u591a\u80bd\u5de5\u7a0b\u6280\u672f\u5f00\u53d1\u9776\u5411\u653e\u5c04\u6027\u836f\u7269\u6765\u6cbb\u7597\u764c\u75c7\u7684\u516c\u53f8\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u57282020\u5e74\u7b2c\u4e09\u5b63\u5ea6\u9886\u6295\u5176\u5929\u4f7f\u8f6e\u3002\u9664\u4e86\u8d44\u91d1\u4e0a\u7684\u652f\u6301\u5916\uff0c\u7ef4\u4e9a\u751f\u7269\u8fd8\u5411Focus-X\u63d0\u4f9b\u4e86\u5168\u9762\u7684\u5b75\u5316\u670d\u52a1\uff0c\u52a9\u529b\u5176\u5b9e\u73b0\u4e86\u4ece&quot;\u6982\u5ff5\u5230\u4ea7\u54c1&quot;\u7684\u8f6c\u5316\u3002<\/p>\n<p><b>\u7d22\u667a\u751f\u7269\u83b7\u5f97&quot;\u6d77\u521b\u6c47\u5341\u4f73\u6d77\u5916\u4eba\u624d\u521b\u4e1a\u9879\u76ee&quot;<\/b><\/p>\n<p>11\u670828\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u7d22\u667a\u751f\u7269\u83b7\u9080\u53c2\u52a0\u4e862022\u6d66\u4e1c\u65b0\u533a\u521b\u65b0\u521b\u4e1a\u5cf0\u4f1a\uff0c\u5e76\u4ece300\u591a\u4e2a\u4f18\u79c0\u9879\u76ee\u4e2d\u8131\u9896\u800c\u51fa\uff0c\u83b7\u5f97&quot;\u6d77\u521b\u6c47\u5341\u4f73\u6d77\u5916\u4eba\u624d\u521b\u4e1a\u9879\u76ee&quot;\u5956\u9879\u8363\u8a89\u3002\u672c\u6b21\u6d77\u521b\u6c47\u7531\u4e0a\u6d77\u5e02\u79d1\u534f\u3001\u6d66\u4e1c\u65b0\u533a\u533a\u59d4\u7ec4\u7ec7\u90e8\u3001\u6d66\u4e1c\u65b0\u533a\u79d1\u7ecf\u59d4\u3001\u81ea\u8d38\u533a\u7ba1\u59d4\u4f1a\u5f20\u6c5f\u7ba1\u7406\u5c40\u5171\u540c\u4e3b\u529e\u3002\u7d22\u667a\u751f\u7269\u5c06\u6301\u7eed\u5728\u6d66\u4e1c\u65b0\u533a\u751f\u7269\u533b\u836f\u548c\u4eba\u5de5\u667a\u80fd\u7684\u9886\u5730\u66f4\u597d\u7684\u96c6\u5408\u8d44\u6e90\u548c\u4eba\u624d\u4f18\u52bf\uff0c\u4e89\u53d6\u901a\u8fc7\u5f15\u8fdb\u66f4\u591a\u4e13\u4e1a\u5316\u4eba\u624d\uff0c\u52a0\u901f\u63a8\u8fdb\u521b\u65b0\u836f\u7269\u7814\u53d1\u9879\u76ee\u3002<\/p>\n<p><b>\u5b50\u77bb+<\/b><b>\u5eb7\u5b81\uff1a\u6784\u5efaCAR-NK<\/b><b>\u7ec6\u80de\u6d78\u6da6\u80bf\u7624\u7ec6\u80de\u5916\u57fa\u8d28\u9776\u5411\u6740\u4f24\u80bf\u7624\u7ec6\u80de\u7684\u4f53\u59163D<\/b><b>\u6a21\u578b<\/b><\/p>\n<p>11\u670822\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u4e0a\u6d77\u5b50\u77bb\u533b\u836f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08&quot;\u5b50\u77bb\u751f\u7269&quot;\uff09\u4e0e\u5eb7\u5b81\u751f\u547d\u79d1\u5b66\u3001\u4eea\u666f\u901a\u5149\u5b66\u79d1\u6280\uff08&quot;\u5965\u6797\u5df4\u65af\u751f\u547d\u79d1\u5b66&quot;\uff09\u5171\u540c\u5ba3\u5e03\uff0c\u7531\u4e09\u65b9\u5171\u540c\u6253\u9020\u7684&quot;\u5b50\u77bb\u751f\u7269\u57fa\u4e8e\u590d\u6742\u75be\u75c5\u6a21\u578b\u548c\u751f\u7269\u6210\u50cf\u7684\u836f\u7269\u8868\u578b\u7b5b\u9009\u5e73\u53f0&quot;\u6b63\u5f0f\u6210\u7acb\u3002<\/p>\n<p>\u5b50\u77bb\u836f\u7269\u8868\u578b\u7b5b\u9009\u5e73\u53f0\u5c06\u5b8c\u7f8e\u6574\u5408\u5b50\u77bb\u751f\u7269\u7684\u590d\u6742\u75be\u75c5\u5efa\u6a21\u6280\u672f\u5e73\u53f0\u3001\u5eb7\u5b81\u751f\u547d\u79d1\u5b66\u9ad8\u8d28\u91cf\u7684\u751f\u7269\u6280\u672f\u4ea7\u54c1\u548c\u5168\u7403\u7ecf\u9a8c\uff0c\u4ee5\u53ca\u4eea\u666f\u901a\u5149\u5b66\u5353\u8d8a\u7684\u751f\u7269\u6210\u50cf\u89e3\u51b3\u65b9\u6848\uff0c\u4e3a\u5ba2\u6237\u63d0\u4f9b\u6700\u9ad8\u8d28\u91cf\u7684\u836f\u7269\u8868\u578b\u7b5b\u9009\u670d\u52a1\u3002<\/p>\n<p><b>Aleta Biotherapeutics<\/b><b>\u5ba3\u5e03CAR-T<\/b><b>\u7ec6\u80de\u7597\u6cd5\u8854\u63a5\u5b50ALETA-001<\/b><b>\u83b7\u5f97\u521b\u65b0\u62a4\u7167\u7684\u8d44\u683c\u8ba4\u5b9a<\/b><\/p>\n<p>\u8fd1\u671f\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684Aleta Biotherapeutics\uff08\u7b80\u79f0&quot;Aleta&quot;\uff09\u5ba3\u5e03\uff0c\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u673a\u6784\uff08MHRA\uff09\u5df2\u6388\u4e88\u516c\u53f8\u5728\u7814\u7ba1\u7ebfALETA-001\uff08CAR-T\u7ec6\u80de\u7597\u6cd5\u8854\u63a5\u5668\uff09\u8fdb\u5165\u521b\u65b0\u8bb8\u53ef\u548c\u8bbf\u95ee\u9014\u5f84\uff08ILAP\uff09\u7684\u521b\u65b0\u62a4\u7167\uff08Innovation Passport\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u60a3\u6709B\u7ec6\u80de\u6076\u6027\u80bf\u7624\u3001\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08NHL\uff09\u548c\u6025\u6027\u6dcb\u5df4\u6bcd\u7ec6\u80de\u7624\u7684\u60a3\u8005\u767d\u8840\u75c5\uff08ALL\uff09\uff0c\u4ee5\u53ca\u5728CD19 CAR-T\u7ec6\u80de\u6cbb\u7597\u540e\u6ca1\u6709\u53cd\u5e94\u6216\u590d\u53d1\u7684\u60a3\u8005\u3002ALETA-001\u9884\u8ba1\u5c06\u4e8e2023\u5e74\u8fdb\u5165\u4e34\u5e8a\u9636\u6bb5\uff0c\u7531\u82f1\u56fd\u764c\u75c7\u7814\u7a76\u4e2d\u5fc3\u7684\u836f\u7269\u5f00\u53d1\u4e2d\u5fc3\u8d5e\u52a9\u5e76\u5f00\u5c551\/2a\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p><b>Cybrexa<\/b><b>\u548cExelixis<\/b><b>\u8fbe\u6210\u72ec\u5bb6\u5408\u4f5c\uff0c\u4e3aExelixis<\/b><b>\u63d0\u4f9b\u6536\u8d2dCBX-12<\/b><b>\u7684\u6743\u5229<\/b><\/p>\n<p>11\u67081\u65e5\uff0c\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u963f\u62c9\u7c73\u8fbe\u548c\u5eb7\u6d85\u72c4\u683c\u5dde\u7ebd\u9ed1\u6587\uff0cExelixis\u548c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684Cybrexa Therapeutics\uff08\u7b80\u79f0&quot;Cybrexa&quot;\uff09\u5ba3\u5e03\uff0c\u53cc\u65b9\u5df2\u7b7e\u8ba2\u72ec\u5bb6\u5408\u4f5c\u534f\u8bae\uff0c\u5411Exelixi\u63d0\u4f9b\u6536\u8d2dCBX-12\uff08alphalex exatecan\uff09\u7684\u6743\u5229\u3002\u6839\u636e\u5408\u4f5c\u534f\u8bae\uff0cExelixis\u5c06\u5411Cybrexa\u652f\u4ed86000\u4e07\u7f8e\u5143\u7684\u9884\u4ed8\u6b3e\uff0c\u4ee5\u6362\u53d6\u5728\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u7ed3\u679c\u516c\u5e03\u540e\u6536\u8d2dCBX-12\u7684\u6743\u5229\uff0c\u5e76\u4e3aCybrexa\u63a8\u8fdb\u5546\u5b9a\u7684\u5f00\u53d1\u548c\u751f\u4ea7\u8ba1\u5212\u63d0\u4f9b\u8d44\u91d1\u3002Cybrexa\u8fd8\u6709\u671b\u83b7\u5f97\u9ad8\u8fbe6.425\u4ebf\u7f8e\u5143\u7684\u989d\u5916\u6536\u76ca\uff0c\u5305\u62ec\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff0c\u4ee5\u53ca\u5728\u8bc4\u4f30\u9884\u5148\u6307\u5b9a\u7684\u4e34\u5e8a\u6570\u636e\u540e\u8d2d\u4e70CBX-12\u7684\u8d39\u7528\u3002<\/p>\n<p>CBX-12\u662f\u4e00\u79cd\u5904\u4e8e\u4e34\u5e8a\u7814\u7a76\u9636\u6bb5first-in-class\u7684\u591a\u80bd\u5076\u8054\u836f\u7269\uff08PDC\uff09\uff0c\u901a\u8fc7alphalex\u6280\u672f\u5c06\u4e00\u79cd\u9ad8\u6548\u7684\u7b2c\u4e8c\u4ee3\u62d3\u6251\u5f02\u6784\u9176I\u6291\u5236\u5242exatecan\u76f4\u63a5\u4f20\u9012\u5230\u80bf\u7624\u7ec6\u80de\uff0c\u63d0\u9ad8\u62d3\u6251\u5f02\u6784\u9176I\u6291\u5236\u5242\u7684\u6709\u6548\u6027\u5e76\u964d\u4f4e\u6bd2\u6027\u3002<\/p>\n<p><b>DTx Pharma<\/b><b>\u548cHAYA Therapeutics<\/b><b>\u5171\u540c\u5165\u9009\u79d1\u777f\u552f\u5b89\u65b0\u516c\u5e03\u7684\u300aRNA Technology Companies to Watch<\/b><b>\u300b\u62a5\u544a<\/b><\/p>\n<p>10\u670825\u65e5\uff0c\u82f1\u56fd\u4f26\u6566\uff0c\u79d1\u777f\u552f\u5b89\u53d1\u5e03\u4e86\u65b0\u7684\u62a5\u544a\u2014\u2014\u300aRNA Technology Companies to Watch\u300b\u3002\u8be5\u62a5\u544a\u7efc\u5408\u5206\u6790\u4e86RNA\u516c\u53f8\u7684\u836f\u7269\u6548\u76ca\u3001\u878d\u8d44\u3001\u7814\u53d1\u6d3b\u52a8\u7b49\uff0c\u63ed\u793a\u4e86\u533b\u5b66\u9886\u57df\u65b0\u5174\u7684RNA\u6770\u51fa\u4f01\u4e1a\u3002\u672c\u6b21\u5171\u6709\u51657\u5bb6\u65b0\u5174\u521b\u65b0RNA\u6280\u672f\u516c\u53f8\u5165\u9009\uff0c\u5176\u4e2d\u5305\u62ec\u4e86\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684DTx Pharma\u548cHAYA Therapeutics\u3002<\/p>\n<p>\u6b64\u5916\uff0cHaya Therapeutics\u8fd8\u5728\u8fd1\u671fLSX\u4e3e\u529e\u7684&quot;European Lifestars Awards&quot;\u4e0a\u8363\u83b7\u4e86\u5e74\u5ea6\u79cd\u5b50\u8f6e\u878d\u8d44\u5956\u3002<\/p>\n<p><b>Domain<\/b><b>\u7528\u4e8e\u6cbb\u7597\u5b9e\u4f53\u7624\u7684EP4R<\/b><b>\u62ee\u6297\u5242DT-9081<\/b><b>\u83b7\u6279\u8fdb\u5165\u4e34\u5e8a<\/b><\/p>\n<p>10\u670819\u65e5\uff0c\u6cd5\u56fd\u65af\u7279\u62c9\u65af\u5821&amp;\u52a0\u62ff\u5927\u8499\u7279\u5229\u5c14\uff0c\u4e00\u5bb6\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e13\u6ce8\u4e8e\u7814\u7a76\u548c\u5f00\u53d1\u9776\u5411G\u86cb\u767d\u5076\u8054\u53d7\u4f53\uff08GPCR\uff09\u514d\u75ab\u80bf\u7624\u5b66\u65b0\u836f\u7684\u751f\u7269\u5236\u836f\u516c\u53f8Domain Therapeutics\uff08\u7b80\u79f0&quot;Domain&quot;\uff09\u5ba3\u5e03\uff0c\u5176\u9996\u4e2a\u5b8c\u5168\u81ea\u6709\u7684IO\u5019\u9009\u836f\u7269DT-9081\uff0c\u5df2\u7ecf\u901a\u8fc7\u4e86\u6cd5\u56fd\u56fd\u5bb6\u836f\u54c1\u548c\u4fdd\u5065\u54c1\u5b89\u5168\u5c40\uff08ANSM\uff09\u548c\u6bd4\u5229\u65f6\u836f\u54c1\u548c\u4fdd\u5065\u54c1\u7ba1\u7406\u5c40\uff08AFMPS\uff09\u7684\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08CTA\uff09\u3002\u968f\u7740\u6b64\u6b21\u4e34\u5e8a\u83b7\u6279\uff0cDomain\u5373\u5c06\u5f00\u542fI\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e14\u6709\u671b\u5728\u4eca\u5e74\u5e74\u5e95\u524d\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\u3002<\/p>\n<p><b>\u5b89\u6d4e\u4e0ePHP<\/b><b>\u5efa\u7acb\u6218\u7565\u5408\u4f5c\uff0c\u643a\u624b\u653b\u514b\u9ad8\u53d1\u75be\u75c5<\/b><\/p>\n<p>10\u670819\u65e5\uff0c\u7f8e\u56fd\u9ebb\u7701\u5251\u6865\u548c\u7ebd\u7ea6\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u5b89\u6d4e\u836f\u4e1a\u548cPopulation Health Partners\u6b63\u5f0f\u5ba3\u5e03\u8fbe\u6210\u6218\u7565\u5408\u4f5c\uff0c\u53cc\u65b9\u56e2\u961f\u5c06\u7d27\u5bc6\u5408\u4f5c\uff0c\u643a\u624b\u653b\u514b\u4eba\u7c7b\u9ad8\u53d1\u75be\u75c5\u96be\u9898\u3002<\/p>\n<p>\u5b89\u6d4e\u4e0ePHP\u5408\u4f5c\u5f00\u59cb\u540e\uff0c\u8fd1\u671f\u5de5\u4f5c\u91cd\u70b9\u5728\u4e8e\u52a0\u901f\u5b89\u6d4e\u4e24\u9879\u4e3b\u8981\u4e34\u5e8a\u7ba1\u7ebf\u7684\u5f00\u53d1\u3002ANJ900\uff08\u4e8c\u7532\u53cc\u80cd\u5ef6\u8fdf\u91ca\u653e\u65b0\u5242\u578b\uff09\u6b63\u5728\u8fdb\u884c3\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u65e8\u5728\u4f7f\u4e8c\u7532\u53cc\u80cd\u53ef\u4ee5\u5b89\u5168\u7528\u4e8e\u5e76\u53d1\u4e2d\u91cd\u5ea6\u6162\u6027\u80be\u75c5\uff08CKD\uff09\u76842\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u3002ANJ908\uff08pradigastat\uff09\u662f\u4e00\u79cd\u521b\u65b0\u7684DGAT1\u6291\u5236\u5242\uff0c\u5df2\u5728\u6162\u6027\u529f\u80fd\u6027\u4fbf\u79d8\u60a3\u8005\u4e2d\u6210\u529f\u5b8c\u62102\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08NCT04620161\uff09\u3002<\/p>\n<p><b>Triumvira<\/b><b>\u5c06\u5728\u65e7\u91d1\u5c71\u5357\u90e8\u5de5\u5382\u6269\u5efa\u7ec6\u80de\u7597\u6cd5\u4ea7\u80fd\uff0c\u4e14\u6b64\u524d\u516c\u5e03\u4e86TAC01-HER2<\/b><b>\u76841\/2<\/b><b>\u671f\u521d\u59cb\u4e34\u5e8a\u6570\u636e<\/b><\/p>\n<p>10\u670819\u65e5\uff0c\u5fb7\u514b\u8428\u65af\u5dde\u5965\u65af\u6c40\u3001\u5357\u65e7\u91d1\u5c71\u548c\u5b89\u5927\u7565\u7701\u6c49\u5bc6\u5c14\u987f\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u4e13\u6ce8\u4e8e\u5f00\u53d1\u65b0\u578b\u3001\u6709\u9488\u5bf9\u6027\u7684\u81ea\u4f53\u548c\u5f02\u4f53TCR-T\u7ec6\u80de\u7597\u6cd5\uff0c\u805a\u7126\u5b9e\u4f53\u7624\u6cbb\u7597\u7684\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8Triumvira Immunologics \uff08&quot;Triumvira&quot;\uff09\u5ba3\u5e03\uff0c\u4e0eAmplifyBio\u8fbe\u6210\u4e00\u9879\u591a\u5e74\u534f\u8bae\uff0c\u5c06\u4f7f\u7528\u5176\u5728\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u5357\u65e7\u91d1\u5c71\u7684\u8bbe\u65bd\u751f\u4ea7\u516c\u53f8\u7ba1\u7ebf\u5185\u7684\u7ec6\u80de\u6cbb\u7597\u5019\u9009\u836f\u7269\u3002Triumvira\u9884\u8ba1\u8be5\u8bbe\u65bd\u5c06\u4e8e2023\u5e74\u5168\u9762\u6295\u5165\u8fd0\u8425\u3002<\/p>\n<p>\u6b64\u524d9\u6708\uff0cTriumvira\u57282022 ESMO\u4e0a\u516c\u5e03\u4e86TAC01-HER2\u6cbb\u7597HER2\u9633\u6027\u5b9e\u4f53\u7624\u76841\/2\u671f\u521d\u59cb\u4e34\u5e8a\u6570\u636e\u3002\u6570\u636e\u8868\u660e\uff0cTAC01-HER2\u5728\u4e24\u4e2a\u7ed9\u836f\u7ec4\u4e2d\u5747\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u5e76\u4e14\u5728\u7ed9\u836f\u5242\u91cf\u8f83\u9ad8\u7684\u90a3\u7ec4\u4e2d\u89c2\u5bdf\u5230\u4e34\u5e8a\u6d3b\u52a8\u7684\u65e9\u671f\u4fe1\u53f7\uff0c\u75be\u75c5\u63a7\u5236\u7387\u4e3a75%\uff0c\u5305\u62ec\u4e00\u4f8b\u90e8\u5206\u7f13\u89e3\u3002<\/p>\n<p><b>\u74a7\u8fb0\u533b\u836f\u53ef\u5165\u8111MEK<\/b><b>\u6291\u5236\u5242ABM-168<\/b><b>\u83b7\u7f8e\u56fdFDA<\/b><b>\u4e34\u5e8a\u8bd5\u9a8c\u8bb8\u53ef\uff0c\u5e76\u4efb\u547d\u6768\u8d5e\u4e1c\u535a\u58eb\u4e3a\u9996\u5e2d\u533b\u5b66\u5b98<\/b><\/p>\n<p>10\u670812\u65e5\uff0c\u4e2d\u56fd\u4e0a\u6d77\/\u7f8e\u56fd\u5723\u5730\u4e9a\u54e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e13\u6ce8\u4e8e\u53ef\u7a81\u7834\u8840\u8111\u5c4f\u969c\u7684\u5c0f\u5206\u5b50\u836f\u7269\u7814\u53d1\u516c\u53f8\u74a7\u8fb0\u533b\u836f\uff08ABM Therapeutics\uff09\u5ba3\u5e03\uff0c\u5176\u81ea\u4e3b\u7814\u53d1\u7684\u53ef\u5165\u8111MEK1\/2\u6291\u5236\u5242ABM-168\u5df2\u83b7\u6279\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\uff08IND\uff09\u6279\u51c6\u3002\u8fd9\u4e5f\u662f\u74a7\u8fb0\u533b\u836f\u7ee7ABM-1310\u4e4b\u540e\uff0c\u5728\u7f8e\u56fd\u83b7\u6279\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7b2c\u4e8c\u6b3e\u81ea\u4e3b\u7814\u53d1\u7684\u836f\u7269\u3002\u968f\u7740\u6b64\u6b21\u83b7\u5f97\u4e34\u5e8a\u8bb8\u53ef\uff0c\u74a7\u8fb0\u533b\u836f\u5373\u5c06\u5f00\u542f\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u5c06\u9488\u5bf9\u665a\u671f\u5b9e\u4f53\u7624\uff0c\u7279\u522b\u662f\u5e76\u53d1\u8111\u8f6c\u79fb\u6216\u539f\u53d1\u6027\u8111\u7624\u60a3\u8005\u8fdb\u884c\u62db\u52df\uff0c\u65e8\u5728\u63a2\u7d22ABM-168\u5728\u8fd9\u7c7b\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u3001\u836f\u4ee3\u52a8\u529b\u5b66\u4ee5\u53ca\u521d\u6b65\u6297\u80bf\u7624\u6d3b\u6027\u3002<\/p>\n<p>\u6b64\u524d10\u670810\u65e5\uff0c\u74a7\u8fb0\u533b\u836f\u5ba3\u5e03\u4efb\u547d\u6768\u8d5e\u4e1c\u535a\u58eb\uff08Zane Yang, M.D.\uff09\u4e3a\u516c\u53f8\u9996\u5e2d\u533b\u5b66\u5b98\uff08CMO\uff09\uff0c\u5168\u9762\u9886\u5bfc\u7ba1\u7406\u74a7\u8fb0\u533b\u836f\u7684\u5168\u7403\u4e34\u5e8a\u5f00\u53d1\u4e8b\u52a1\uff0c\u5236\u5b9a\u548c\u5b9e\u65bd\u4e34\u5e8a\u53d1\u5c55\u6218\u7565\uff0c\u53c2\u4e0e\u516c\u53f8\u6574\u4f53\u4e1a\u52a1\u548c\u53d1\u5c55\u6218\u7565\u7684\u89c4\u5212\u548c\u5b9e\u65bd\u3002\u6768\u535a\u58eb\u5177\u6709\u975e\u5e38\u6df1\u539a\u7684\u4e13\u4e1a\u548c\u5b66\u672f\u80cc\u666f\u3001\u4e30\u5bcc\u7684\u4e34\u5e8a\u7814\u53d1\u548c\u7ba1\u7406\u7ecf\u9a8c\u3002<\/p>\n<p><b>\u542f\u6108\u751f\u7269Q-1801<\/b><b>\u9879\u76ee\u83b7\u7f8e\u56fdFDA<\/b><b>\u4e34\u5e8a\u6279\u4ef6<\/b><\/p>\n<p>9\u670824\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u542f\u6108\u751f\u7269\u5ba3\u5e03\uff0c\u5176\u81ea\u4e3b\u7814\u53d1\u7684Q-1801\u9879\u76ee\u83b7\u5f97\u7f8e\u56fdFDA\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u901a\u77e5\u4e66\uff0c\u540c\u65f6\u6b63\u5728\u8fdb\u884c\u4e2d\u56fdIND\u7533\u62a5\u3002Q-1801\u7531\u542f\u6108\u751f\u7269\u5229\u7528\u5176\u6297\u4f53\u5de5\u7a0b\u6280\u672f\u5e73\u53f0\u5f00\u53d1\uff0c\u4e3a\u5168\u7403\u9996\u521b\u540c\u65f6\u9776\u5411SIRP\u03b1\u53caPD-L1\u7684\u53cc\u7279\u5f02\u6027\u6297\u4f53\u3002Q-1801\u4e5f\u662f\u542f\u6108\u751f\u7269\u7b2c\u4e8c\u4e2a\u4e34\u5e8a\u7533\u62a5\u9879\u76ee\uff0c\u8fdb\u4e00\u6b65\u5c55\u793a\u4e86\u542f\u6108\u751f\u7269\u7684\u81ea\u4e3b\u7814\u53d1\u548c\u521b\u65b0\u80fd\u529b\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e0a\u6d772022\u5e7412\u67081\u65e5 \/\u7f8e\u901a\u793e\/ &#8212;&nbsp;\u9762\u5bf9\u4e0d\u65ad\u53d8\u5316\u7684\u5c40\u52bf\uff0c\u6280\u672f\u521b\u65b0\u4f9d\u65e7\u662f\u751f\u7269\u533b\u836f\u4f01\u4e1a\u957f\u8fdc\u53d1\u5c55\u6c38\u6052\u7684\u4e3b\u65cb\u5f8b\uff0c\u4e3a\u4f01\u4e1a\u6e90\u6e90\u4e0d\u65ad\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7eed\u63a8\u52a8\u7814\u53d1&quot;\u4ece0\u52301&quot;\u8f6c\u5316\u4ee5\u53ca\u5546\u4e1a\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7ef4\u4e9a12\u5bb6\u6295\u8d44\u5b75\u5316\u4f01\u4e1a\u53d6\u5f97\u4e86\u663e\u8457\u7684\u6210\u679c\u4e0e\u8fdb\u5c55\uff1aFocus-X Therapeutics\u4e0e\u8f90\u8054\u533b\u836f\u6210\u529f\u8fbe\u6210\u6536\u8d2d\u534f\u8bae\uff1bAleta Biotherapeutics\u3001Domain\u3001Triumvira\u3001\u74a7\u8fb0\u533b\u836f\u3001\u542f\u6108\u751f\u7269\u987a\u5229\u63a8\u8fdb\u7814\u53d1\u7ba1\u7ebf\uff1b\u5b50\u77bb\u751f\u7269\u3001Cybrexa\u3001\u5b89\u6d4e\u836f\u4e1a\u5206\u522b\u5728\u5404\u81ea\u7ec6\u5206\u9886\u57df\u8fbe\u6210\u91cd\u8981\u5408\u4f5c\uff1bDTx Pharma\u3001HAYA Therapeutics\u3001\u7d22\u667a\u751f\u7269\u63a5\u8fde\u65a9\u83b7\u6b8a\u8363\u3002\u4e0b\u9762\uff0c\u8ba9\u6211\u4eec\u5171\u540c\u4e00\u89c8\u4ed6\u4eec\u7684\u53d1\u5c55\u52a8\u6001\u3002 \u7ef4\u4e9a\u751f\u7269\u6295\u8d44\u5b75\u5316\u516c\u53f8Focus-X Therapeutics\uff0c\u4e0e\u8f90\u8054\u533b\u836f\u6210\u529f\u8fbe\u6210\u6536\u8d2d\u534f\u8bae 2022\u5e7411\u670829\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u6295\u8d44\u5b75\u5316\u7684\u6838\u7d20\u836f\u7269\u516c\u53f8Focus-X Therapeutics\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;Focus-X&quot;\uff09\uff0c\u4e0e\u8f90\u8054\u533b\u836f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;\u8f90\u8054\u533b\u836f&quot;\uff09\u6210\u529f\u8fbe\u6210\u6536\u8d2d\u534f\u8bae\u3002\u6839\u636e\u6b64\u6b21\u6536\u8d2d\u534f\u8bae\u6761\u6b3e\uff0c\u8f90\u8054\u533b\u836f\u5c06\u652f\u4ed8Focus-X\u603b\u8ba12.45\u4ebf\u7f8e\u5143\u7684\u4ea4\u6613\u5bf9\u4ef7\uff0c\u5176\u4e2d\u5305\u62ec\u9884\u4ed8\u6b3e\u4ee5\u53ca\u6f5c\u5728\u7684\u5f00\u53d1\u3001\u6ce8\u518c\u3001\u9500\u552e\u91cc\u7a0b\u7891\u8d39\u7528\u548c\u5546\u4e1a\u9500\u552e\u7684\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\u3002\u8be5\u9879\u6536\u8d2d\u9884\u8ba1\u5c06\u4e8e2023\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u3002\u8fd9\u4e5f\u662f\u7ef4\u4e9a\u6295\u8d44\u5b75\u5316\u516c\u53f8\u4e2d\u7ee7Dogma\u3001Totient\u540e\u53c8\u4e00\u4e2a\u5728\u4e34\u5e8a\u524d\u9636\u6bb5\u88ab\u6536\u8d2d\u7684\u9879\u76ee\uff0c\u518d\u6b21\u9a8c\u8bc1\u4e86\u7ef4\u4e9a\u6295\u8d44\u56e2\u961f\u53d1\u6398\u9879\u76ee\u7684\u80fd\u529b\u4ee5\u53ca\u4e13\u4e1a\u7684\u6295\u540e\u652f\u6301\u3002 Focus-X\u662f\u4e00\u5bb6\u57fa\u4e8e\u81ea\u8eab\u4e13\u6709\u7684\u591a\u80bd\u5de5\u7a0b\u6280\u672f\u5f00\u53d1\u9776\u5411\u653e\u5c04\u6027\u836f\u7269\u6765\u6cbb\u7597\u764c\u75c7\u7684\u516c\u53f8\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u57282020\u5e74\u7b2c\u4e09\u5b63\u5ea6\u9886\u6295\u5176\u5929\u4f7f\u8f6e\u3002\u9664\u4e86\u8d44\u91d1\u4e0a\u7684\u652f\u6301\u5916\uff0c\u7ef4\u4e9a\u751f\u7269\u8fd8\u5411Focus-X\u63d0\u4f9b\u4e86\u5168\u9762\u7684\u5b75\u5316\u670d\u52a1\uff0c\u52a9\u529b\u5176\u5b9e\u73b0\u4e86\u4ece&quot;\u6982\u5ff5\u5230\u4ea7\u54c1&quot;\u7684\u8f6c\u5316\u3002 \u7d22\u667a\u751f\u7269\u83b7\u5f97&quot;\u6d77\u521b\u6c47\u5341\u4f73\u6d77\u5916\u4eba\u624d\u521b\u4e1a\u9879\u76ee&quot; 11\u670828\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u7d22\u667a\u751f\u7269\u83b7\u9080\u53c2\u52a0\u4e862022\u6d66\u4e1c\u65b0\u533a\u521b\u65b0\u521b\u4e1a\u5cf0\u4f1a\uff0c\u5e76\u4ece300\u591a\u4e2a\u4f18\u79c0\u9879\u76ee\u4e2d\u8131\u9896\u800c\u51fa\uff0c\u83b7\u5f97&quot;\u6d77\u521b\u6c47\u5341\u4f73\u6d77\u5916\u4eba\u624d\u521b\u4e1a\u9879\u76ee&quot;\u5956\u9879\u8363\u8a89\u3002\u672c\u6b21\u6d77\u521b\u6c47\u7531\u4e0a\u6d77\u5e02\u79d1\u534f\u3001\u6d66\u4e1c\u65b0\u533a\u533a\u59d4\u7ec4\u7ec7\u90e8\u3001\u6d66\u4e1c\u65b0\u533a\u79d1\u7ecf\u59d4\u3001\u81ea\u8d38\u533a\u7ba1\u59d4\u4f1a\u5f20\u6c5f\u7ba1\u7406\u5c40\u5171\u540c\u4e3b\u529e\u3002\u7d22\u667a\u751f\u7269\u5c06\u6301\u7eed\u5728\u6d66\u4e1c\u65b0\u533a\u751f\u7269\u533b\u836f\u548c\u4eba\u5de5\u667a\u80fd\u7684\u9886\u5730\u66f4\u597d\u7684\u96c6\u5408\u8d44\u6e90\u548c\u4eba\u624d\u4f18\u52bf\uff0c\u4e89\u53d6\u901a\u8fc7\u5f15\u8fdb\u66f4\u591a\u4e13\u4e1a\u5316\u4eba\u624d\uff0c\u52a0\u901f\u63a8\u8fdb\u521b\u65b0\u836f\u7269\u7814\u53d1\u9879\u76ee\u3002 \u5b50\u77bb+\u5eb7\u5b81\uff1a\u6784\u5efaCAR-NK\u7ec6\u80de\u6d78\u6da6\u80bf\u7624\u7ec6\u80de\u5916\u57fa\u8d28\u9776\u5411\u6740\u4f24\u80bf\u7624\u7ec6\u80de\u7684\u4f53\u59163D\u6a21\u578b 11\u670822\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u4e0a\u6d77\u5b50\u77bb\u533b\u836f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08&quot;\u5b50\u77bb\u751f\u7269&quot;\uff09\u4e0e\u5eb7\u5b81\u751f\u547d\u79d1\u5b66\u3001\u4eea\u666f\u901a\u5149\u5b66\u79d1\u6280\uff08&quot;\u5965\u6797\u5df4\u65af\u751f\u547d\u79d1\u5b66&quot;\uff09\u5171\u540c\u5ba3\u5e03\uff0c\u7531\u4e09\u65b9\u5171\u540c\u6253\u9020\u7684&quot;\u5b50\u77bb\u751f\u7269\u57fa\u4e8e\u590d\u6742\u75be\u75c5\u6a21\u578b\u548c\u751f\u7269\u6210\u50cf\u7684\u836f\u7269\u8868\u578b\u7b5b\u9009\u5e73\u53f0&quot;\u6b63\u5f0f\u6210\u7acb\u3002 \u5b50\u77bb\u836f\u7269\u8868\u578b\u7b5b\u9009\u5e73\u53f0\u5c06\u5b8c\u7f8e\u6574\u5408\u5b50\u77bb\u751f\u7269\u7684\u590d\u6742\u75be\u75c5\u5efa\u6a21\u6280\u672f\u5e73\u53f0\u3001\u5eb7\u5b81\u751f\u547d\u79d1\u5b66\u9ad8\u8d28\u91cf\u7684\u751f\u7269\u6280\u672f\u4ea7\u54c1\u548c\u5168\u7403\u7ecf\u9a8c\uff0c\u4ee5\u53ca\u4eea\u666f\u901a\u5149\u5b66\u5353\u8d8a\u7684\u751f\u7269\u6210\u50cf\u89e3\u51b3\u65b9\u6848\uff0c\u4e3a\u5ba2\u6237\u63d0\u4f9b\u6700\u9ad8\u8d28\u91cf\u7684\u836f\u7269\u8868\u578b\u7b5b\u9009\u670d\u52a1\u3002 Aleta Biotherapeutics\u5ba3\u5e03CAR-T\u7ec6\u80de\u7597\u6cd5\u8854\u63a5\u5b50ALETA-001\u83b7\u5f97\u521b\u65b0\u62a4\u7167\u7684\u8d44\u683c\u8ba4\u5b9a \u8fd1\u671f\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684Aleta Biotherapeutics\uff08\u7b80\u79f0&quot;Aleta&quot;\uff09\u5ba3\u5e03\uff0c\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u673a\u6784\uff08MHRA\uff09\u5df2\u6388\u4e88\u516c\u53f8\u5728\u7814\u7ba1\u7ebfALETA-001\uff08CAR-T\u7ec6\u80de\u7597\u6cd5\u8854\u63a5\u5668\uff09\u8fdb\u5165\u521b\u65b0\u8bb8\u53ef\u548c\u8bbf\u95ee\u9014\u5f84\uff08ILAP\uff09\u7684\u521b\u65b0\u62a4\u7167\uff08Innovation Passport\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u60a3\u6709B\u7ec6\u80de\u6076\u6027\u80bf\u7624\u3001\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08NHL\uff09\u548c\u6025\u6027\u6dcb\u5df4\u6bcd\u7ec6\u80de\u7624\u7684\u60a3\u8005\u767d\u8840\u75c5\uff08ALL\uff09\uff0c\u4ee5\u53ca\u5728CD19 CAR-T\u7ec6\u80de\u6cbb\u7597\u540e\u6ca1\u6709\u53cd\u5e94\u6216\u590d\u53d1\u7684\u60a3\u8005\u3002ALETA-001\u9884\u8ba1\u5c06\u4e8e2023\u5e74\u8fdb\u5165\u4e34\u5e8a\u9636\u6bb5\uff0c\u7531\u82f1\u56fd\u764c\u75c7\u7814\u7a76\u4e2d\u5fc3\u7684\u836f\u7269\u5f00\u53d1\u4e2d\u5fc3\u8d5e\u52a9\u5e76\u5f00\u5c551\/2a\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 Cybrexa\u548cExelixis\u8fbe\u6210\u72ec\u5bb6\u5408\u4f5c\uff0c\u4e3aExelixis\u63d0\u4f9b\u6536\u8d2dCBX-12\u7684\u6743\u5229 11\u67081\u65e5\uff0c\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u963f\u62c9\u7c73\u8fbe\u548c\u5eb7\u6d85\u72c4\u683c\u5dde\u7ebd\u9ed1\u6587\uff0cExelixis\u548c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684Cybrexa Therapeutics\uff08\u7b80\u79f0&quot;Cybrexa&quot;\uff09\u5ba3\u5e03\uff0c\u53cc\u65b9\u5df2\u7b7e\u8ba2\u72ec\u5bb6\u5408\u4f5c\u534f\u8bae\uff0c\u5411Exelixi\u63d0\u4f9b\u6536\u8d2dCBX-12\uff08alphalex exatecan\uff09\u7684\u6743\u5229\u3002\u6839\u636e\u5408\u4f5c\u534f\u8bae\uff0cExelixis\u5c06\u5411Cybrexa\u652f\u4ed86000\u4e07\u7f8e\u5143\u7684\u9884\u4ed8\u6b3e\uff0c\u4ee5\u6362\u53d6\u5728\u7b2c\u4e00\u9636\u6bb5\u4e34\u5e8a\u7ed3\u679c\u516c\u5e03\u540e\u6536\u8d2dCBX-12\u7684\u6743\u5229\uff0c\u5e76\u4e3aCybrexa\u63a8\u8fdb\u5546\u5b9a\u7684\u5f00\u53d1\u548c\u751f\u4ea7\u8ba1\u5212\u63d0\u4f9b\u8d44\u91d1\u3002Cybrexa\u8fd8\u6709\u671b\u83b7\u5f97\u9ad8\u8fbe6.425\u4ebf\u7f8e\u5143\u7684\u989d\u5916\u6536\u76ca\uff0c\u5305\u62ec\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff0c\u4ee5\u53ca\u5728\u8bc4\u4f30\u9884\u5148\u6307\u5b9a\u7684\u4e34\u5e8a\u6570\u636e\u540e\u8d2d\u4e70CBX-12\u7684\u8d39\u7528\u3002 CBX-12\u662f\u4e00\u79cd\u5904\u4e8e\u4e34\u5e8a\u7814\u7a76\u9636\u6bb5first-in-class\u7684\u591a\u80bd\u5076\u8054\u836f\u7269\uff08PDC\uff09\uff0c\u901a\u8fc7alphalex\u6280\u672f\u5c06\u4e00\u79cd\u9ad8\u6548\u7684\u7b2c\u4e8c\u4ee3\u62d3\u6251\u5f02\u6784\u9176I\u6291\u5236\u5242exatecan\u76f4\u63a5\u4f20\u9012\u5230\u80bf\u7624\u7ec6\u80de\uff0c\u63d0\u9ad8\u62d3\u6251\u5f02\u6784\u9176I\u6291\u5236\u5242\u7684\u6709\u6548\u6027\u5e76\u964d\u4f4e\u6bd2\u6027\u3002 DTx Pharma\u548cHAYA Therapeutics\u5171\u540c\u5165\u9009\u79d1\u777f\u552f\u5b89\u65b0\u516c\u5e03\u7684\u300aRNA Technology Companies to Watch\u300b\u62a5\u544a 10\u670825\u65e5\uff0c\u82f1\u56fd\u4f26\u6566\uff0c\u79d1\u777f\u552f\u5b89\u53d1\u5e03\u4e86\u65b0\u7684\u62a5\u544a\u2014\u2014\u300aRNA Technology Companies to Watch\u300b\u3002\u8be5\u62a5\u544a\u7efc\u5408\u5206\u6790\u4e86RNA\u516c\u53f8\u7684\u836f\u7269\u6548\u76ca\u3001\u878d\u8d44\u3001\u7814\u53d1\u6d3b\u52a8\u7b49\uff0c\u63ed\u793a\u4e86\u533b\u5b66\u9886\u57df\u65b0\u5174\u7684RNA\u6770\u51fa\u4f01\u4e1a\u3002\u672c\u6b21\u5171\u6709\u51657\u5bb6\u65b0\u5174\u521b\u65b0RNA\u6280\u672f\u516c\u53f8\u5165\u9009\uff0c\u5176\u4e2d\u5305\u62ec\u4e86\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684DTx Pharma\u548cHAYA Therapeutics\u3002 \u6b64\u5916\uff0cHaya Therapeutics\u8fd8\u5728\u8fd1\u671fLSX\u4e3e\u529e\u7684&quot;European Lifestars Awards&quot;\u4e0a\u8363\u83b7\u4e86\u5e74\u5ea6\u79cd\u5b50\u8f6e\u878d\u8d44\u5956\u3002 Domain\u7528\u4e8e\u6cbb\u7597\u5b9e\u4f53\u7624\u7684EP4R\u62ee\u6297\u5242DT-9081\u83b7\u6279\u8fdb\u5165\u4e34\u5e8a 10\u670819\u65e5\uff0c\u6cd5\u56fd\u65af\u7279\u62c9\u65af\u5821&amp;\u52a0\u62ff\u5927\u8499\u7279\u5229\u5c14\uff0c\u4e00\u5bb6\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e13\u6ce8\u4e8e\u7814\u7a76\u548c\u5f00\u53d1\u9776\u5411G\u86cb\u767d\u5076\u8054\u53d7\u4f53\uff08GPCR\uff09\u514d\u75ab\u80bf\u7624\u5b66\u65b0\u836f\u7684\u751f\u7269\u5236\u836f\u516c\u53f8Domain Therapeutics\uff08\u7b80\u79f0&quot;Domain&quot;\uff09\u5ba3\u5e03\uff0c\u5176\u9996\u4e2a\u5b8c\u5168\u81ea\u6709\u7684IO\u5019\u9009\u836f\u7269DT-9081\uff0c\u5df2\u7ecf\u901a\u8fc7\u4e86\u6cd5\u56fd\u56fd\u5bb6\u836f\u54c1\u548c\u4fdd\u5065\u54c1\u5b89\u5168\u5c40\uff08ANSM\uff09\u548c\u6bd4\u5229\u65f6\u836f\u54c1\u548c\u4fdd\u5065\u54c1\u7ba1\u7406\u5c40\uff08AFMPS\uff09\u7684\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\uff08CTA\uff09\u3002\u968f\u7740\u6b64\u6b21\u4e34\u5e8a\u83b7\u6279\uff0cDomain\u5373\u5c06\u5f00\u542fI\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e14\u6709\u671b\u5728\u4eca\u5e74\u5e74\u5e95\u524d\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\u3002 \u5b89\u6d4e\u4e0ePHP\u5efa\u7acb\u6218\u7565\u5408\u4f5c\uff0c\u643a\u624b\u653b\u514b\u9ad8\u53d1\u75be\u75c5 10\u670819\u65e5\uff0c\u7f8e\u56fd\u9ebb\u7701\u5251\u6865\u548c\u7ebd\u7ea6\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u5b89\u6d4e\u836f\u4e1a\u548cPopulation Health Partners\u6b63\u5f0f\u5ba3\u5e03\u8fbe\u6210\u6218\u7565\u5408\u4f5c\uff0c\u53cc\u65b9\u56e2\u961f\u5c06\u7d27\u5bc6\u5408\u4f5c\uff0c\u643a\u624b\u653b\u514b\u4eba\u7c7b\u9ad8\u53d1\u75be\u75c5\u96be\u9898\u3002 \u5b89\u6d4e\u4e0ePHP\u5408\u4f5c\u5f00\u59cb\u540e\uff0c\u8fd1\u671f\u5de5\u4f5c\u91cd\u70b9\u5728\u4e8e\u52a0\u901f\u5b89\u6d4e\u4e24\u9879\u4e3b\u8981\u4e34\u5e8a\u7ba1\u7ebf\u7684\u5f00\u53d1\u3002ANJ900\uff08\u4e8c\u7532\u53cc\u80cd\u5ef6\u8fdf\u91ca\u653e\u65b0\u5242\u578b\uff09\u6b63\u5728\u8fdb\u884c3\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u65e8\u5728\u4f7f\u4e8c\u7532\u53cc\u80cd\u53ef\u4ee5\u5b89\u5168\u7528\u4e8e\u5e76\u53d1\u4e2d\u91cd\u5ea6\u6162\u6027\u80be\u75c5\uff08CKD\uff09\u76842\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u3002ANJ908\uff08pradigastat\uff09\u662f\u4e00\u79cd\u521b\u65b0\u7684DGAT1\u6291\u5236\u5242\uff0c\u5df2\u5728\u6162\u6027\u529f\u80fd\u6027\u4fbf\u79d8\u60a3\u8005\u4e2d\u6210\u529f\u5b8c\u62102\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08NCT04620161\uff09\u3002 Triumvira\u5c06\u5728\u65e7\u91d1\u5c71\u5357\u90e8\u5de5\u5382\u6269\u5efa\u7ec6\u80de\u7597\u6cd5\u4ea7\u80fd\uff0c\u4e14\u6b64\u524d\u516c\u5e03\u4e86TAC01-HER2\u76841\/2\u671f\u521d\u59cb\u4e34\u5e8a\u6570\u636e&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2022120118100086947\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-86947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/86947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=86947"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/86947\/revisions"}],"predecessor-version":[{"id":86948,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/86947\/revisions\/86948"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=86947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=86947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=86947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}